Title |
Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients*
|
---|---|
Published in |
Anais Brasileiros de Dermatologia, January 2017
|
DOI | 10.1590/abd1806-4841.20176724 |
Pubmed ID | |
Authors |
Rossilene Conceição da Silva Cruz, Samira Bührer-Sékula, Maria Lúcia F. Penna, Gerson Oliveira Penna, Sinésio Talhari |
Abstract |
In this review, the most relevant and current epidemiological data, the main clinical, laboratory and therapeutical aspects of leprosy are presented. Detailed discussion of the main drugs used for leprosy treatment, their most relevant adverse effects, evolution of the therapeutic regimen, from dapsone as a monotherapy to the proposed polychemotherapy by World Health Organization (WHO) can be found in this CME. We specifically highlight the drug acceptability, reduction in treatment duration and the most recent proposal of a single therapeutic regimen, with a fixed six months duration, for all clinical presentations, regardless of their classification. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 169 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 35 | 21% |
Student > Master | 22 | 13% |
Researcher | 12 | 7% |
Student > Doctoral Student | 12 | 7% |
Student > Postgraduate | 9 | 5% |
Other | 18 | 11% |
Unknown | 61 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 35 | 21% |
Nursing and Health Professions | 19 | 11% |
Biochemistry, Genetics and Molecular Biology | 11 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
Agricultural and Biological Sciences | 7 | 4% |
Other | 23 | 14% |
Unknown | 66 | 39% |